The global pulse oximeters market is slated to expand at around 6.5% CAGR during the forecast period (2022 to 2027).
The ability of pulse oximeters to verify the health of patients at their homes and comfort, as well as accurate detection of serious ailments, will drive rapid growth in the coming years. In light of the current global situation, the industry has enormous potential for growth.
The demand is also fueled by an aging population and chronic illnesses. Medical costs are expected to rise, and the need for ‘on-the-spot’ monitoring would create lucrative opportunities for the industry. Obesity, poor eating habits, and sedentary lifestyles can all lead to cardiac problems, fueling the demand for pulse oximeters. Other main market factors include the increased production of alternative therapies, the adoption of oximeter instruments, and the use of low perfusion technologies. These instruments are used to monitor patients’ vital signs and are critical to their overall wellbeing. Industry participants are said to see opportunities in the promotion of oximeter devices with novel and advanced properties. Sleep apnea, chronic obstructive pulmonary disease, and cardiac abnormalities all have the potential to drive market growth in the near future.
With the passage of time, more user-friendly and high-tech devices have emerged, resulting in increased development. Better market prospects are arising from increased demand for homecare services and patient comfort. Rapid approvals for new technology, as well as the need for remote patient monitoring, are said to raise earnings. Lack of knowledge about the availability of successful therapies, on the other hand, prevents the industry from gaining further market share.
Pulse oximeters of high quality are important for the early diagnosis and treatment of COVID-19 patients. During this time, the manufacturing and supply chains for pulse oximeters are expected to face difficulties, as most companies are operating at half capacity. Furthermore, trade barriers in the most affected countries are likely to stymie product delivery. However, as COVID-19 cases continue to rise at an exponential pace, manufacturers are working to ensure a sufficient supply of fingertip and handheld pulse oximeters to countries in desperate need.
With the involvement of numerous global and regional producers, the Pulse Oximeters Market is fragmented. To increase their market share, key players are expected to use various strategies such as product launches and acquisitions. Other major projects, such as licensing deals and strategic alliances, are being undertaken by key industry players to enhance their market presence.
The overall industry is categorized into products, applications, and geographies. The market is segmented by product type, such as fingertip, handheld, and so on. The market has been dominated by handheld devices. Their profits were attributed to the growing use of ‘key parameter’ checking devices and surgeries around the world. Early detection of chronic diseases allows for more innovative treatments and fewer complications. Handheld devices have allowed this to happen.
Homecare, hospitals, cardiac & breathing centers, and other kinds of healthcare establishments constitute the applications. Health facilities and hospitals led the market in terms of applications, and this trend is expected to continue during the forecast period. COVID-19 infections are common in long-term care facilities, and residents are constantly monitored for symptoms by checking critical respiratory parameters. During the COVID-19 pandemic, demand for pulse oximeters is expected to rise from home healthcare centers and long-term care facilities.
Due to increased recognition of the value of tracking respiratory vitals among the general population, North America dominated the pulse oximeter market and held the largest revenue share over the review period. Furthermore, a pulse oximeter is considered a necessary necessity for outpatients and patients who choose to be treated at home and is reimbursed after sufficient reporting. As a result, demand growth is projected to be supported by a favourable reimbursement infrastructure. Furthermore, health agencies are providing medical practitioners with information on COVID-19 in order to help them better handle the pandemic situation.
All medical device manufacturers are likely to be impacted by recent regulatory changes in Europe. While factors such as changes in labeling standards and changes in rules and regulations governing the delivery of medical devices can slow down the approval process, they may have long-term benefits for approved products, such as increased quality and fewer product recalls.
Market players in Asia Pacific are realizing the opportunity and launching new products tailored to the region’s emerging economies. Despite the fact that Asia Pacific’s birth rate is slightly decreasing, the number of babies born every day is still very high. As a result, the market has a huge target population.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013